Cormedix Inc (CRMD) Stock Price, Quote & News

Company Profile

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was in...

Industry: Biotechnology

Sector: Healthcare

Phone: 908 517 9500

Fax: 908 375 8272

Website: www.cormedix.com

Address:

300 Connell Drive, Suite 4200, Berkeley Heights, United States

SweStonk Dec. 5 at 11:21 AM

$CRMD $30 @ share IMMINENT.

1 · Reply

Damian23 Dec. 5 at 10:43 AM

$CRMD And you guys still in this ship? Come on look at the management, then there are people defending that they keep increasing their sharecount.... They keep selling at market open and then are granted option exercises at 1/3 current valuation at expense of shareholders.... Crazy, not many times you see this... Dont lie to yourselves there are plenty of better investments out there... Sell and dont look back, protect your money. These guys are ripping you off. Just my opinion , Icould be wrong.

1 · Reply

AtomicAIerts Dec. 5 at 10:18 AM

$CRMD AtomicAlerts Scalp Alert Direction: LONG Entry: $10.65 TP1: $11.35 | TP2: $12.05 | TP3: $12.75 Stop Loss: $10.05 👉 https://atomicalerts.com

0 · Reply

Derek22us Dec. 5 at 6:09 AM

$CRMD India cracking down and banning options traders. Claims that some "big-sized participants, through the use of sophisticated technology, are using “manipulative” practices to game the system, affecting the integrity of the market" AKA screwing retail investors. 48.4 billion rupees ($570 million) in alleged unlawful gains seized from a giant US based market maker. See story on MSN

0 · Reply

Iightning Dec. 5 at 5:31 AM

1ightning® Premium Options Alert (Actionable) Ticker: $CRMD Contract: Dec 19 $10C Entry: 0.90 Exit: 1.19 Return: +31.87% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

Direwolf0110 Dec. 5 at 12:50 AM

$CRMD I really need to trade this. The SP cycle is so consistent. Time to remember the other brokerage password...

0 · Reply

tballgame Dec. 4 at 11:35 PM

$CRMD here we go crmd here we go. Longs days are coming 🥶

0 · Reply

Iightning Dec. 4 at 11:19 PM

1ightning® Premium Options Alert (Actionable) Ticker: $CRMD Contract: Dec 19 $10C Entry: 0.90 Exit: 1.19 Return: +31.87% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

Derek22us Dec. 4 at 10:52 PM

$CRMD Beware of the fee feeding options hustlers. If you are unable to buy real shares with real money, go to the casino with borrowed money destroy your life. There is a reason why there are no operable windows in casino hotels. 17,445,320 CRMD shares are borrowed and shorted by sheisters hoping for a share price decline. Who would want to enable these despicable parasites with their shares.

1 · Reply

Christiandg Dec. 4 at 9:20 PM

$CRMD I think we've bottomed here and will climb over the next couple months...we'll see

0 · Reply

CorMedix: Raised Guidance, NOL Confidence, And Rezzayo Optionality Justify A Hold Rating

Nov 12, 2025, 4:05 PM EST - 22 days ago

Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update

TLPH

Nov 12, 2025, 11:49 AM EST - 22 days ago

CorMedix Q3 Profit Soars As DefenCath Dialysis Demand Exceeds Expectations

Nov 12, 2025, 11:11 AM EST - 22 days ago

CorMedix Inc. (CRMD) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 7:30 AM EST - 22 days ago

CorMedix Inc. Reports Third Quarter 2025 Financial Results and Updates FY 2025 Guidance

Oct 31, 2025, 8:30 AM EDT - 4 weeks ago

CorMedix Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 12, 2025

Oct 23, 2025, 11:29 PM EDT - 6 weeks ago

CorMedix: Strong Buy After Strong Developments And A Strategy Before Earnings

Oct 23, 2025, 8:30 AM EDT - 6 weeks ago

CorMedix Inc. Receives Innovative Technology Designation From Vizient for DefenCath

Oct 22, 2025, 4:05 PM EDT - 6 weeks ago

Halper Sadeh LLC Encourages CorMedix Inc. Shareholders to Contact the Firm to Discuss Their Rights

Oct 20, 2025, 9:42 AM EDT - 6 weeks ago

CRMD, RANI, CELC, RAPT: four biotech stocks flying high today and why

CELC RANI RAPT

Oct 20, 2025, 7:30 AM EDT - 6 weeks ago

CorMedix Inc. Announces Preliminary Third Quarter 2025 Results and Raises 2025 Net Revenue Guidance

Sep 29, 2025, 8:30 AM EDT - 2 months ago

CorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO

Sep 22, 2025, 4:46 AM EDT - 2 months ago

CorMedix: Strong Adoption Curve And Policy Environment

Sep 10, 2025, 1:18 PM EDT - 3 months ago

CorMedix Inc. (CRMD) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 8, 2025, 8:30 AM EDT - 3 months ago

CorMedix Announces Strategic Minority Investment in Talphera

TLPH

Sep 8, 2025, 8:30 AM EDT - 3 months ago

Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market

TLPH

Sep 2, 2025, 7:30 AM EDT - 3 months ago

CorMedix Completes Acquisition of Melinta Therapeutics, Raises Financial Guidance and Announces New Leadership Team

Aug 28, 2025, 8:30 AM EDT - 3 months ago

CorMedix to Participate in Upcoming Investor Conferences

Aug 26, 2025, 2:41 AM EDT - 3 months ago

CorMedix: The Undervalued Breakthrough

Aug 8, 2025, 3:16 PM EDT - 4 months ago

CorMedix, Inc. (CRMD) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 10:49 AM EDT - 4 months ago

CorMedix to Buy Melinta Therapeutics for $300 Million

Aug 7, 2025, 7:10 AM EDT - 4 months ago

Melinta Therapeutics Announces Strategic Acquisition by CorMedix, Underscoring Its Portfolio Value and Industry Leadership

Aug 7, 2025, 7:00 AM EDT - 4 months ago

CorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings

Aug 7, 2025, 7:00 AM EDT - 4 months ago

Cormedix Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update

Jun 30, 2025, 2:24 PM EDT - 5 months ago

CorMedix Analyst Says Investors Could Be Further Rewarded

Jun 30, 2025, 2:14 PM EDT - 5 months ago

CorMedix Seems Significantly Undervalued

Jun 27, 2025, 9:09 AM EDT - 5 months ago

Concentrix Posts Downbeat Earnings, Joins CorMedix And Other Big Stocks Moving Lower In Friday's Pre-Market Session

CNXC

Jun 27, 2025, 8:00 AM EDT - 5 months ago

CorMedix Inc. Announces Pricing of Public Offering of Common Stock

Jun 26, 2025, 4:01 PM EDT - 5 months ago

CorMedix Inc. Announces Proposed Public Offering of Common Stock

Jun 23, 2025, 7:30 AM EDT - 5 months ago

CorMedix inc. Announces Customer Implementation

Jun 5, 2025, 12:37 AM EDT - 6 months ago

CorMedix: DefenCath In Exponential Growth Phase With Robust Market Position

Jun 4, 2025, 12:41 PM EDT - 6 months ago

CorMedix: Exceeding Expectations

May 30, 2025, 8:30 AM EDT - 6 months ago

CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference

May 15, 2025, 8:30 AM EDT - 7 months ago

CorMedix Inc. to Participate in the RBC Global Healthcare Conference

May 6, 2025, 11:59 AM EDT - 7 months ago

CorMedix, Inc. (CRMD) Q1 2025 Earnings Call Transcript

May 6, 2025, 7:30 AM EDT - 7 months ago

CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

Apr 29, 2025, 8:30 AM EDT - 7 months ago

CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025

Apr 8, 2025, 7:30 AM EDT - 8 months ago

Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance

Apr 2, 2025, 8:30 AM EDT - 8 months ago

CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

Mar 28, 2025, 3:01 AM EDT - 9 months ago

CorMedix: A Fair-Priced Biotech Company With A Bright Future

Mar 25, 2025, 10:51 AM EDT - 9 months ago

CorMedix Inc. (CRMD) Q4 2024 Earnings Call Transcript

Mar 25, 2025, 7:30 AM EDT - 9 months ago

CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

SweStonk Dec. 5 at 11:21 AM

$CRMD $30 @ share IMMINENT.

1 · Reply

Damian23 Dec. 5 at 10:43 AM

1 · Reply

AtomicAIerts Dec. 5 at 10:18 AM

$CRMD AtomicAlerts Scalp Alert Direction: LONG Entry: $10.65 TP1: $11.35 | TP2: $12.05 | TP3: $12.75 Stop Loss: $10.05 👉 https://atomicalerts.com

0 · Reply

Derek22us Dec. 5 at 6:09 AM

0 · Reply

Iightning Dec. 5 at 5:31 AM

1ightning® Premium Options Alert (Actionable) Ticker: $CRMD Contract: Dec 19 $10C Entry: 0.90 Exit: 1.19 Return: +31.87% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

Direwolf0110 Dec. 5 at 12:50 AM

$CRMD I really need to trade this. The SP cycle is so consistent. Time to remember the other brokerage password...

0 · Reply

tballgame Dec. 4 at 11:35 PM

$CRMD here we go crmd here we go. Longs days are coming 🥶

0 · Reply

Iightning Dec. 4 at 11:19 PM

1ightning® Premium Options Alert (Actionable) Ticker: $CRMD Contract: Dec 19 $10C Entry: 0.90 Exit: 1.19 Return: +31.87% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

Derek22us Dec. 4 at 10:52 PM

1 · Reply

Christiandg Dec. 4 at 9:20 PM

$CRMD I think we've bottomed here and will climb over the next couple months...we'll see

0 · Reply

bobmoney Dec. 4 at 8:32 PM

$TLPH $CRMD oh, TLPH is -- under accumulation -- !

0 · Reply

bobmoney Dec. 4 at 8:15 PM

$TLPH $CRMD CRMD CEO Todisco, brilliant pharma background ... now a lead TLPH Board of Director... enough said... !

0 · Reply

SuperGreenToday Dec. 4 at 7:34 PM

$CRMD Share Price: $10.62 Contract Selected: May 15, 2026 $10 Calls Buy Zone: $1.57 – $1.94 Target Zone: $2.50 – $3.05 Potential Upside: 50% ROI Time to Expiration: 161 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

4ezmony Dec. 4 at 6:37 PM

$CRMD Still 🐂ish!! Let's Go!!

0 · Reply

GardeningGirl Dec. 4 at 6:28 PM

$CRMD cat

0 · Reply

Derek22us Dec. 4 at 6:05 PM

$CRMD I get the feeling that CRMD is about to break loose from the trading garbage and sprint higher. The 700/1100 skunks are destined to be roadkill.

1 · Reply

Miketj Dec. 4 at 6:02 PM

$CRMD

0 · Reply

Miketj Dec. 4 at 5:56 PM

$CRMD I will also continue selling all the way up to 11.50. If it dosent get to 11.50. Worse case senrio. I have secured plenty of profit and will reload on the dips. ✌️😎. GLA

0 · Reply

Miketj Dec. 4 at 5:50 PM

$CRMD as per usual been banking all day…pay myself first FOMO later. And as per usual another play working exactly the way I planned. Went to 9.50🤔✅. Added a shit ton ✅. Only thing left is 11.50 .😎✌️

0 · Reply

JackNapier22 Dec. 4 at 5:43 PM

$CRMD So the IWM just broke out of a 4 year downtrend, and this trades at $10.60? Ha, ok. I don’t miss it.

1 · Reply

CaliEmpress Dec. 4 at 5:28 PM

$CRMD 🫶

1 · Reply

mattsprat Dec. 4 at 5:25 PM

$CRMD

0 · Reply

Market Cap	770.56M
Revenue (ttm)	43.47M
Net Income (ttm)	-17.93M
EPS (ttm)	N/A
PE Ratio	7.14
Forward PE	4.49
Profit Margin	-41.25%
Debt to Equity Ratio	0.00

Volume	2,462,500
Avg Vol	2,661,136
Day's Range	N/A - N/A
Shares Out	78.79M
Stochastic %K	93%
Beta	1.32
Analysts	Strong Sell
Price Target	$19.00